B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
about
Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responsesCurrent status of biomarkers for prostate cancerImmune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?Immune checkpoint blockade therapy for bladder cancer treatmentThe Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesThe inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survivalCloning and characterization of porcine 4Ig-B7-H3: a potent inhibitor of porcine T-cell activationAntibody Therapies in Cancer.Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancerIncreased B7-H4 expression during esophageal squamous cell carcinogenesis is associated with IL-6/STAT3 signaling pathway activation in miceRational combinations of immunotherapeutics that target discrete pathways.Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancerInhibitors of B7-CD28 costimulation in urologic malignancies.Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38.Yin-Yang of costimulation: crucial controls of immune tolerance and function.T cell coinhibition and immunotherapy in human breast cancerSerum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stageThe coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer.B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcomeConsiderations for combined immune checkpoint modulation and radiation treatment.Novel diagnostic biomarkers for prostate cancer.Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction.Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.B7-h3 and its role in antitumor immunityB7-H3 expression in breast cancer and upregulation of VEGF through gene silenceB7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.Structure and cancer immunotherapy of the B7 family member B7xB7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis.Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma.Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity.B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.Development of a novel monoclonal antibody to B7-H4: characterization and biological activity.Prognostic role of high B7-H4 expression in patients with solid tumors: a meta-analysis.A novel monoclonal antibody against mouse B7-H3 developed in rats.Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response.Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.
P2860
Q24316331-D19D7A60-7D79-4E5C-A2A7-1FE0BFD94CA9Q24600574-7DE02198-C5FB-40B6-B585-EA2FE94F6FAAQ26740601-0657CE13-44B5-405C-93ED-1FEB6F24DD03Q26744139-4472D4A7-5474-4E22-A718-06A29C4A6008Q26750672-2039B158-765C-4705-90D9-45F4FA2604D5Q26825652-D5B1B156-E600-4133-9F8F-76B9984EFF7CQ26829844-C94F0A96-7B94-406A-A330-A735213F1370Q28743206-B5655CF8-7F26-4C7C-99DD-68E973E8B423Q31104000-5337C179-115B-4C7F-AD97-B6CA149F432CQ33520828-59B9DD27-DAA9-4D5B-8F37-318C600C26F3Q33598323-FF86B291-5077-47A5-92D5-0FDC652FB4DEQ33606144-59B0F30F-21A6-4C70-9780-8271B537B604Q33688959-A9C62016-14A0-497A-A70A-044AB4F4D75FQ33825711-18EF7457-830C-4B81-8295-B98C43C5B880Q33827752-0EE8BA96-F4DA-4E2D-9AFC-ED6ECA20D528Q33828459-B68071F8-52B0-4AD6-B81C-F77B2C0372F7Q33872168-A93F4387-9EC2-4BDC-9FC8-BE3D9281B776Q33936154-542A10CC-B92E-44D9-92D5-64401035E0A4Q34052745-382A5EFF-5B0D-4B16-8A25-EF12B3912DD7Q34093668-A24E2CB5-6B0C-47B5-A38E-05859DE66074Q34105913-8608D0F5-8D07-4623-BFF5-D47B1E3A23A3Q34174871-B024D7EC-3CF2-4A01-8BEA-B26BF9B206C5Q34231678-39CCD944-5011-4EFC-BBD7-43FDC673295DQ34291894-57C6583F-39F1-4689-925F-D682FAB880F1Q34298906-2E209E31-BC7A-479F-9C7F-E946BF60CA70Q34347703-029A38FD-4D70-49B8-9C90-FFF9CB7F6F41Q34356712-5048A745-22CC-4E49-8B2A-6B642FFD1488Q34446315-F6D0044F-A1AD-424A-98A1-4F8E50E81602Q34501651-F5FA214B-359A-4536-8D3E-4B264B8D2A41Q34577158-21B71E23-6BE1-43B4-9F10-8C37449C4B8CQ34605921-5C7F94D5-394E-44A2-9B03-B4E22332F364Q34935785-E57746A5-41DD-4C15-A501-61373D251D0BQ35032331-34F507D8-96E4-4636-AFAC-718BA12DE024Q35144600-0C908D1D-E9E1-4115-A0BF-CB711EDC9AE9Q35660790-9E1F5815-ED0D-40A8-9C1F-E19C295958A8Q35959218-6A746811-EA63-4D84-A8D9-8BEA33E876A2Q35983676-B162E799-31CA-4954-ADB3-4922E374E745Q36168870-02C95D80-A1AB-4977-B167-59F6E250953FQ36207260-A9EBBD13-D1FF-4954-AB59-7DBC178CA1ADQ36363019-39B0A35C-403E-4DA4-A821-021DBD16F0D7
P2860
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
B7-H3 and B7x are highly expre ...... isease spread and poor outcome
@ast
B7-H3 and B7x are highly expre ...... isease spread and poor outcome
@en
type
label
B7-H3 and B7x are highly expre ...... isease spread and poor outcome
@ast
B7-H3 and B7x are highly expre ...... isease spread and poor outcome
@en
prefLabel
B7-H3 and B7x are highly expre ...... isease spread and poor outcome
@ast
B7-H3 and B7x are highly expre ...... isease spread and poor outcome
@en
P2093
P2860
P356
P1476
B7-H3 and B7x are highly expre ...... isease spread and poor outcome
@en
P2093
Angel M Serio
James A Eastham
Padmanee Sharma
Peter T Scardino
R Houston Thompson
Victor E Reuter
Xingxing Zang
P2860
P304
19458-19463
P356
10.1073/PNAS.0709802104
P407
P577
2007-11-27T00:00:00Z